(Q46650015)

23 December 2017

title

Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice (English)

1 reference

23 December 2017

0 references

Esther Berrocoso

1

0 references

author name string

Juan A Mico

series ordinal

2

1 reference

23 December 2017

publication date

14 April 2008

1 reference

23 December 2017

The International Journal of Neuropsychopharmacology

published in

1 reference

23 December 2017

volume

12

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

61-71

1 reference

23 December 2017

Ethical guidelines for investigations of experimental pain in conscious animals

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Is there a role for 5-HT1A agonists in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Pindolol augmentation of antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Central neural mechanisms that interrelate sensory and affective dimensions of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Potentiation of the antinociceptive effect of clomipramine by a 5-ht(1A) antagonist in neuropathic pain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Strategies for producing faster acting antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

The efficacy and safety of venlafaxine in the prophylaxis of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Venlafaxine Treatment of Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Clinical experience with dual action antidepressants in different chronic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Fluvoxamine modulates pain sensation and affective processing of pain in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Descending control of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

21 January 2018

Antidepressants and pain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

Control of dorsal raphé 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Long-lasting delayed hyperalgesia after subchronic swim stress

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

The Role of 5-HT1A Receptors in Research Strategy for Extensive Pain Treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

Inescapable shock-induced potentiation of morphine analgesia in rats: sites of action

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708008766

7 January 2021

10.1017/S1461145708008766

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017